A. S. Poroshina

A. S. Poroshina

Auto-generated profile, based on publicly available information

A. S. Poroshina

National Research Center Institute of Immunology

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2023 in Allergy
Verified
Journal Article
Open access
GBGeorgii Brazhnikov
Georgii Brazhnikov
ESEvgenii Smolnikov
Evgenii Smolnikov
ALAlla Litovkina
Alla Litovkina
TJTianchi Jiang
Tianchi Jiang
ASArtem Shatilov
Artem Shatilov
RCRaffaela A. Campana
Raffaela A. Campana
Background: The nature of epitopes on Bet v 1 recognized by natural IgG antibodies of birch pollen allergic patients and birch pollen‐exposed but non‐sensitized subjects has not been studied in detail.Objective: To investigate IgE and IgG recognition of Bet v 1 and to study the effects of natural Bet v 1‐specific IgG antibodies on IgE recognition of Bet v 1 and Bet v 1‐induced basophil activation.Methods: Sera from birch pollen allergic patients (BPA, n = 76), allergic patients without birch pollen allergy (NBPA, n = 40) and non‐allergic individuals (NA, n = 48) were tested for IgE, IgG as well as IgG1 and IgG4 reactivity to folded recombinant Bet v 1, two unfolded recombinant Bet v 1 fragments comprising the N‐terminal (F1) and C‐terminal half of Bet v 1 (F2) and unfolded peptides spanning the corresponding sequences of Bet v 1 and the apple allergen Mal d 1 by ELISA or micro‐array analysis. The ability of Bet v 1‐specific serum antibodies from non‐allergic subjects to inhibit allergic patients IgE or IgG binding to rBet v 1 or to unfolded Bet v 1‐derivatives was assessed by competition ELISAs. Furthermore, the ability of serum antibodies from allergic and non‐allergic subjects to modulate Bet v 1‐induced basophil activation was investigated using rat basophilic leukaemia cells expressing the human FcεRI which had been loaded with IgE from BPA patients.Results: IgE antibodies from BPA patients react almost exclusively with conformational epitopes whereas IgG, IgG1 and IgG4 antibodies from BPA, NBPA and NA subjects recognize mainly unfolded and sequential epitopes. IgG competition studies show that IgG specific for unfolded/sequential Bet v 1 epitopes is not inhibited by folded Bet v 1 and hence the latter seem to represent cryptic epitopes. IgG reactivity to Bet v 1 peptides did not correlate with IgG reactivity to the corresponding Mal d 1 peptides and therefore does not seem to be a result of primary sensitization to PR10 allergen‐containing food. Natural Bet v 1‐specific IgG antibodies inhibited IgE binding to Bet v 1 only poorly and could even enhance Bet v 1‐specific basophil activation.Conclusion: IgE and IgG antibodies from BPA patients and birch pollen‐exposed non‐sensitized subjects recognize different epitopes. These findings explain why natural allergen‐specific IgG do not protect against allergic symptoms and suggest that allergen‐specific IgE and IgG have different clonal origin.

19 October 2023 in Allergy
Verified
Journal Article
Closed access
MKMusa Khaitov
Musa Khaitov
ISIgor Shilovskiy
Igor Shilovskiy
RVRudolf Valenta
Rudolf Valenta
MWMilena Weber
Milena Weber
AKArtem Korneev
Artem Korneev
VSVeronika Skvortsova
Veronika Skvortsova

1 January 2023 in Immunologiya
Verified
Journal Article
Open access
APA.S. Poroshina
A.S. Poroshina
NSNadezhda N. Shershakova
Nadezhda N. Shershakova
ISIgor Shilovskiy
Igor Shilovskiy
AKA.G. Kadushkin
A.G. Kadushkin
BBBelarusian State Medical University of the Ministry of Health of the Republic of Belarus
Belarusian State Medical University of the Ministry of Health of the Republic of Belarus
MKM.R. Khaitov
M.R. Khaitov
Роль ИЛ-25, ИЛ-33 и TSLP в развитии кортикостероидной резистентности

1 January 2022 in Immunologiya
Verified
Journal Article
Closed access
OEOlga Elisyutina
Olga Elisyutina
NSNadezhda N. Shershakova
Nadezhda N. Shershakova
VSValery Smirnov
Valery Smirnov
ISIgor Shilovskiy
Igor Shilovskiy
AKA.V. Korneev
A.V. Korneev
MKM.R. Khaitov
M.R. Khaitov
Новые подходы к аллерген-специфической иммунотерапии (АСИТ): разработка рекомбинантной вакцины от аллергии на пыльцу березы

1 January 2022 in Immunologiya
Verified
Journal Article
Closed access
OEOlga Elisyutina
Olga Elisyutina
NSNadezhda N. Shershakova
Nadezhda N. Shershakova
VSValery Smirnov
Valery Smirnov
ISIgor Shilovskiy
Igor Shilovskiy
AKA.V. Korneev
A.V. Korneev
MKM.R. Khaitov
M.R. Khaitov
Новые подходы к аллерген-специфической иммунотерапии (АСИТ): разработка рекомбинантной вакцины от аллергии на пыльцу березы

1 January 2023 in Immunologiya
Verified
Journal Article
Open access
MBMaria Byazrova
Maria Byazrova
APA.S. Poroshina
A.S. Poroshina
MSM.M. Sukhova
M.M. Sukhova
EFE.A. Frolov
E.A. Frolov
ASA.B. Shilkina
A.B. Shilkina
AFAlexander V Filatov
Alexander V Filatov
Продукция цитокинов наивными В-лимфоцитами и В-клетками памяти при стимуляции in vitro